Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease
Clinical trial NCT05843916 · COMPLETED
Trial details
- NCT number
- NCT05843916
- Sponsor
- Bio Sidus SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2024-09-19
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.